Summary of the interim report Significant events during the third quarterOn July 12, AcouSort announces that the Company and GenSensor will collaborate to combine AcouSort’s acoustofluidics technology with GenSensor’s Biology First Process Analytical Technology to accelerate bioprocess design and improve monitoring systems for bioreactor culturing. On July 23, AcouSort announces that the Company has been…
Through a consortium consisting of the company’s management, board of directors, founders and major shareholders, AcouSort has received loan guarantees of approximately SEK 4.5 million. Together with current cash position and known future revenues, the loan guarantees secure the execution of AcouSort’s planned activities into Q3 of 2025. AcouSort will now work to establish the…
In order to further strengthen its presence in the flow cytometry space, AcouSort has initiated two important collaborations placing instruments at University of Ottawa, Canada, and Van Andel Institute, Michigan, USA, respectively. As earlier reported, AcouSort collaborates with Dr Vera Tang at University of Ottawa to develop applications concerning isolation of cells from dissociate tissue…
AcouSort has received an order for a six-month rental and application support for an AcouWash system from a leading global pharma company. Initial revenues amount to EUR 14,000. The rental period commenced at the beginning of October and was kicked off with an on-site installation and training at one of the customer’s R&D labs. The…
During the first half of October, AcouSort will participate in two conferences: the DSEV conference in Denmark and the MOVE conference in Serbia. Both conferences focus on the very exciting developments in research in extracellular vesicles (EV). First up was the DSEV conference organized by the Danish Society for Extracellular Vesicles. The conference gathers the…
AcouSort has been selected for full sponsorship by the Indian Department of Biotechnology (DBT), Ministry of Science & Technology, for participation in Global Bio-India 2024, which will be held in New Delhi, India, September 12-14, 2024. The Indian Life Science market is vibrant and has shown a significant growth over the last years. Participation in…
AcouSort has entered into a formal collaboration with Dr Alfonso Blanco, Director of Flow Cytometry at Conway Institute, University College Dublin (UCD). Studying Extracellular Vesicles (EVs) with flow cytometry is increasingly popular and there is a massive interest in using the technique to further deepen the understanding of these intriguing nanoparticles. The collaboration involves the…
On September 4-6, AcouSort will attend ISCT Europe in Gothenburg, Sweden, a conference that gathers an extensive network of cell and gene therapy professionals to address current topics and challenges to drive the field forward and break down barriers to enable greater access to patients. ISCT Europe offers a great opportunity for AcouSort to connect…
Summary of the report Second quarter 2024 for the GroupNet sales amounted to TSEK 961 (1,816)Result before tax amounted to TSEK -4,714 (-3,193)Result per share* was SEK -0.32 (-0.24)Equity ratio** amounted to 61% (58%) on June 30, 2024 Second quarter 2024 for the Parent companyNet sales amounted to TSEK 960 (1,816)Result before tax amounted to TSEK…
Over the past years, AcouSort and Werfen have collaborated on the use of acoustofluidics technology to enable hemolysis detection in point-of-care (POC) diagnostic instruments. Using AcouSort background technology, the parties have jointly developed the acoustofluidic technology now implemented in Werfen’s groundbreaking GEM Premier 7000 system for point-of-care blood gas analysis. The new system was introduced…
"*" indicates required fields
AcouSort AB
Medicon Village
223 81 Lund
Sweden